The metastatic melanoma therapeutics market is estimated to be valued at US$ 8011.15 Mn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Metastatic melanoma refers to melanoma that has spread from the primary tumor site to other organs of the body such as lungs, brain, and liver. Melanoma ... Read more

Metastatic malignant melanoma arises from the transformation and growth of melanocytes which are pigment-producing skin cells. Advanced stage metastatic melanoma that has spread beyond the skin to other organs such as lymph nodes, lungs, brain, or other parts of the body is one of the most aggressive types of skin cancer and has relatively poor prognosis. Targeted therapies and immunotherapy drugs are being used to treat metastatic melanoma. Some of the targeted therapies used are BRAF ... Read more